These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11109514)

  • 1. [Pharmacological activity of the new adamantane derivative--potential antiparkinson preparation during subchronic administration].
    Val'dman EA
    Eksp Klin Farmakol; 2000; 63(5):3-6. PubMed ID: 11109514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of hemantane on the generative function and gonad morphology in rats].
    Smol'nikova NM; Nemova EP; Sorokina AV; Val'dman EA; Durnev AD
    Eksp Klin Farmakol; 2004; 67(6):45-7. PubMed ID: 15707015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)].
    Andiarzhanova EA; Val'dman EA; Kudrin VS; Raevskiĭ KS; Voronina TA
    Eksp Klin Farmakol; 2001; 64(6):13-6. PubMed ID: 11871228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The acute and subchronic effects of hemantane on [3H]-dopamine reuptake in rat striatal synaptosomes ex vivo].
    Abaimov DA; Kovalev GI
    Eksp Klin Farmakol; 2007; 70(4):11-4. PubMed ID: 18078034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the potential antiparkinsonian agent adamantane derivative on ion channels of NMDA glutamate receptors].
    Elshanskaia MV; Sobolevskiĭ AI; Val'dman EA; Khodorov BI
    Eksp Klin Farmakol; 2001; 64(1):18-21. PubMed ID: 11544796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane].
    Nezhinskaia GI; Val'dman EA; Nazarov PG; Sapronov NS
    Eksp Klin Farmakol; 2003; 66(3):44-6. PubMed ID: 12924233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of neurophysiological effects of adamantane derivatives in the experimental parkinsonism model].
    Katunina EA; Samoĭlova EV; Val'dman EA; Nerobkova LN; Voronina TA; Avakian GN
    Eksp Klin Farmakol; 2004; 67(2):16-8. PubMed ID: 15188753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity].
    Val'dman EA; Nerobkova LN; Voronina TA
    Eksp Klin Farmakol; 2004; 67(1):7-10. PubMed ID: 15079899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotropic activity of a potential antiparkinson agent himantane].
    Nezhinskaia GI; Val'dman EA; Nazarov PG; Voronina TA
    Eksp Klin Farmakol; 2001; 64(2):60-3. PubMed ID: 11548451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
    Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of rats during one-year administration of fluphenazine and subsequent withdrawal period.
    Trzeciak HI; Herman ZS; Szkilnik R; Opiełka L; Laskawiec G; Kryk A; Kmicińska M; Stańda J; Obuchowicz E; Bień E
    Pol J Pharmacol Pharm; 1986; 38(1):9-20. PubMed ID: 3763488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice].
    Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI
    Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitrazepam and its combined administration with fenfluramine and cyproheptadine on explorative behaviour, muscle tone and coordination in normal mice and in mice with isolation syndrome.
    Petkov VV
    Acta Physiol Pharmacol Bulg; 1980; 6(3):66-74. PubMed ID: 7197112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antiparkinson activity of a new adamantane derivative].
    Val'dman EA; Voronina TA; Nerobkova LN
    Eksp Klin Farmakol; 1999; 62(4):3-6. PubMed ID: 10513325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the distribution of 3[H]-himantane in the brain structures and the thymus of rats].
    Kovalev GI; Rodionov AP; Petrenko ES; Zolotarev IuA
    Eksp Klin Farmakol; 2003; 66(3):50-2. PubMed ID: 12924235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subchronic effects of gamma-hydroxybutyrate on isolation-induced aggression in male mice.
    Navarro JF; Pedraza C; González F
    Methods Find Exp Clin Pharmacol; 2007; 29(6):379-82. PubMed ID: 17922064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
    Tronci E; Simola N; Borsini F; Schintu N; Frau L; Carminati P; Morelli M
    Eur J Pharmacol; 2007 Jul; 566(1-3):94-102. PubMed ID: 17445798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
    Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of himantane and amantadine effects in experimental intracerebral posttraumatic hematoma].
    Kotel'nikova SO; Nepoklonov AV; Kokshenev II; Ivanova EA; Kraĭneva VA; Val'dman EA; Garibova TL; Voronina TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):63-6. PubMed ID: 23235415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.